| The Study of Long-term Outcomes of GR1802 in Patients With Chronic Rhinosinusitis With Nasal Polyps (NCT06015243) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2023-08-18 |
| A Study of Blood Pressure Control During Cancer Treatment (NCT06023576) | Memorial Sloan Kettering Cancer Center | 2023-08-18 |
| Pharmacogenomics IND Commercial SNP Clinical Study - Abiraterone and Single Nucleotide Polymorphisms (NCT03348670) | Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair | 2023-08-18 |
| Effect of Menopause Hormone Therapy In Postmenopausal Women With CSVD And MCI (NCT05982470) | Beijing Tiantan Hospital | 2023-08-18 |
| First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors (NCT05875168) | Daiichi Sankyo | 2023-08-18 |
| TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma (NCT03529448) | Grupo Español de Investigación en Neurooncología | 2023-08-18 |
| A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines (NCT05978037) | University of Oxford | 2023-08-18 |
| Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer (NCT06050317) | Shandong Cancer Hospital and Institute | 2023-08-18 |
| Evaluating Different Doses of Orelabrutinib in MCL (NCT05978739) | InnoCare Pharma Inc. | 2023-08-18 |
| Lorlatinib as the First-line Treatment in China Advanced ALK+ NSCLC (NCT06092086) | Guangdong Association of Clinical Trials | 2023-08-18 |
| A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED (NCT05966493) | Glaukos Corporation | 2023-08-17 |
| TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases (NCT05948813) | TYK Medicines, Inc | 2023-08-17 |
| RY_SW01 Cell Injection Therapy in Active Lupus Nephritis (NCT06058078) | Jiangsu Renocell Biotech Company | 2023-08-17 |
| Defining a PK and PD Model for Peripheral Analgesia After IV Oxytocin (NCT05929339) | Wake Forest University Health Sciences | 2023-08-17 |
| A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors (NCT05914116) | DualityBio Inc. | 2023-08-17 |
| Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients (NCT05776979) | M.D. Anderson Cancer Center | 2023-08-17 |
| A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV) (NCT05996471) | ViiV Healthcare | 2023-08-17 |
| The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS) (NCT05882903) | Oticara Australia PTY LTD | 2023-08-17 |
| Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits (NCT05654506) | Mayo Clinic | 2023-08-17 |
| A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer (NCT06007937) | Memorial Sloan Kettering Cancer Center | 2023-08-17 |
| CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma (NCT06149169) | Shanghai Ming Ju Biotechnology Co., Ltd. | 2023-08-17 |
| A Study of DB-1310 in Advanced/Metastatic Solid Tumors (NCT05785741) | DualityBio Inc. | 2023-08-17 |
| Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly (NCT06004752) | Peking Union Medical College Hospital | 2023-08-17 |
| Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients (NCT05637216) | Shaw Cancer Center | 2023-08-17 |
| LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome. (NCT06018766) | Steven Hays, MD | 2023-08-17 |
| A Study of GNC-035 in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematological Malignancies (NCT05944978) | Sichuan Baili Pharmaceutical Co., Ltd. | 2023-08-16 |
| A Study of Avutometinib and Defactinib in People With Thyroid Cancer (NCT06007924) | Memorial Sloan Kettering Cancer Center | 2023-08-16 |
| FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms (NCT06858618) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2023-08-16 |
| Organ Preservation in Rectal AdenoCa Using Hypofractionated Pelvic RT(Hypo-OPRA) (NCT06991465) | Neil Kopek | 2023-08-16 |
| Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer (NCT05710406) | Alliance for Clinical Trials in Oncology | 2023-08-16 |
| RC48 Combined With Tislelizumab for Second-line Treatment of HER2 Expression in Recurrent Cervical Cancer (NCT06063018) | Peking Union Medical College Hospital | 2023-08-16 |
| BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (NCT05558982) | Georgetown University | 2023-08-16 |
| A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies (NCT05885555) | Novartis Pharmaceuticals | 2023-08-16 |
| Eltrombopag for Peripheral Blood Stem Cell Harvest (NCT05961410) | National Taiwan University Hospital | 2023-08-15 |
| Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC (NCT05272865) | LaSanta S A S | 2023-08-15 |
| Study of Cryoablation and Nirogacestat for Desmoid Tumor (NCT05949099) | Nam Bui | 2023-08-15 |
| Effect of L-Glutamine on Pulmonary Artery Pressure in Patients With Non-Transfusion-Dependent Thalassemia (NCT07210450) | Mazandaran University of Medical Sciences | 2023-08-15 |
| Organ Preservation Following Enverolimab-based Total Neoadjuvant Therapy for Locally Advanced Very Low Rectal Cancer (NCT05969847) | 池畔 | 2023-08-15 |
| Neoadjuvant Aumolertinib in Patients With AI-diagnosed EGFR-mutant High-risk Pulmonary Ground-glass Opacity. (NCT05946460) | The First Affiliated Hospital of Guangzhou Medical University | 2023-08-15 |
| A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age (NCT05995275) | ModernaTX, Inc. | 2023-08-15 |
| PXL-Platinum 330 in Eyes With Corneal Thinning Conditions (NCT05489510) | Vishal Jhanji | 2023-08-15 |
| Study of Organ Perfusion in Heart Transplantation in Children (NCT06032195) | Dr. F. Köhler Chemie GmbH | 2023-08-15 |
| KN026 Plus Chemotherapy ± KN-046 in HER2 Positive Colorectal Cancer and Biliary Carcinoma (NCT05985707) | Peking University Cancer Hospital & Institute | 2023-08-15 |
| Therapeutic Photobiomodulation and Tretament of Spasticity (NCT06536751) | University of Nove de Julho | 2023-08-15 |
| Efficacy and Safety of Black Seed Oil With Vonoprazan Based Triple Therapy in Treatment of Helicobacter Pylori (NCT05957432) | Ain Shams University | 2023-08-15 |
| Linperlisib in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma (NCT05949944) | Sun Yat-sen University | 2023-08-15 |
| Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations (NCT05820152) | Neurophth Therapeutics Inc | 2023-08-15 |
| Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease (NCT04838301) | University of Arizona | 2023-08-15 |
| Scheduled Autologous PRP Guided Injection in the Maxillary Bony Defects (NCT07108933) | Horus University | 2023-08-15 |
| Gene Therapy(FT-003) for Wet AMD (NCT06492863) | Frontera Therapeutics | 2023-08-15 |
| A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis (NCT06028438) | Janssen Research & Development, LLC | 2023-08-15 |
| Targeting Endoplasmic Reticulum Stress in Human Hypertension (NCT06025630) | University of North Texas Health Science Center | 2023-08-15 |
| Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing (NCT06145308) | Peking Union Medical College | 2023-08-15 |
| Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma (NCT05983237) | Jun Guo | 2023-08-15 |
| REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation (NCT05902533) | University of Cincinnati | 2023-08-14 |
| Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation (NCT04203316) | Children's Oncology Group | 2023-08-14 |
| Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC (NCT06001567) | Second Affiliated Hospital of Guangzhou Medical University | 2023-08-14 |
| Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression (NCT04798612) | Zealand University Hospital | 2023-08-14 |
| A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma (NCT05418972) | Melanoma Institute Australia | 2023-08-14 |
| A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd)-Based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With Primary Plasma Cell Leukemia (NCT05979363) | Institute of Hematology & Blood Diseases Hospital, China | 2023-08-14 |
| A Phase II/III Study of HR070803 in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate and Bevacizumab Versus FOLFOX in Combination With Bevacizumab for First-line Treatment of Advanced Colorectal Cancer (NCT05945901) | Jiangsu HengRui Medicine Co., Ltd. | 2023-08-14 |
| Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements. (NCT06085976) | Clinica Universidad de Navarra, Universidad de Navarra | 2023-08-14 |
| Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer Patients (NCT06780748) | National Cancer Center, Korea | 2023-08-13 |
| Efficacy and Safety of HRS9531 Injection in Type 2 Diabetes Subjects (NCT05966272) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2023-08-12 |
| SCION: SABR and Checkpoint Inhibition of NSCLC (NCT04944173) | University of British Columbia | 2023-08-11 |
| Single Dose IV Methadone for Post-Op Pain (NCT05425420) | Kanecia Obie Zimmerman | 2023-08-11 |
| A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes Mellitus (NCT06202079) | Gan and Lee Pharmaceuticals, USA | 2023-08-11 |
| ArtemiCoffee in Patients With Rising PSA (NCT05478239) | Zin W Myint | 2023-08-11 |
| Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy With SPACEOAR TM for Patients With Low-to-intermediate Risk Localized Prostate Cancer (DESAR-L) (NCT06461819) | Samsung Medical Center | 2023-08-11 |
| Onabotulinum Toxin A (Botox) in the Treatment of Pharyngo-esophageal Dysphagia (NCT04695600) | All India Institute of Medical Sciences | 2023-08-11 |
| Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia (NCT04994808) | Fred Hutchinson Cancer Center | 2023-08-11 |
| NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma (NCT06012695) | Novelwise Pharmaceutical Corporation | 2023-08-11 |
| Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout (NCT05818085) | Atom Therapeutics Co., Ltd | 2023-08-11 |
| A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors. (NCT06015048) | Jiangsu HengRui Medicine Co., Ltd. | 2023-08-11 |
| Orelabrutinib Combined With Rituximab and Chemotherapy for Relapsed/Refractory B-Cell Lymphoma Patients With Central Nervous System Involvement (NCT05926427) | Ruijin Hospital | 2023-08-10 |
| Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors (NCT05407441) | Susan Chi, MD | 2023-08-10 |
| SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI (NCT06020066) | Fudan University | 2023-08-10 |
| A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines (NCT05933512) | Sinocelltech Ltd. | 2023-08-10 |
| Study of Disitamab Vedotin and Anlotinib in Patients With HR-Negative, HER2-Low-Expressing Metastatic Breast Cancer (NCT06000033) | Qilu Hospital of Shandong University | 2023-08-10 |
| Lenvatinib, Sintilimab Plus SIRT for Unresectable HCC (NCT05992584) | Second Affiliated Hospital of Guangzhou Medical University | 2023-08-10 |
| Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia (NCT06532058) | Changzhou Qianhong Bio-pharma Co., Ltd. | 2023-08-10 |
| Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer (NCT05978401) | Guangzhou Gloria Biosciences Co., Ltd. | 2023-08-10 |
| Study of the Effectiveness of Treatment of Sarcopenia With the Use of a Medicinal Product (Nandrolone), Comprehensive Physiotherapy and Diet (NCT05978206) | National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland | 2023-08-10 |
| Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma (NCT05960201) | Asan Medical Center | 2023-08-10 |
| A Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004 Capsule in DILI Subjects (NCT06019936) | Xi'An Aolitai Pharmaceutical Technology Co Ltd | 2023-08-10 |
| Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma (NCT05861050) | City of Hope Medical Center | 2023-08-10 |
| SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer (NCT05826509) | Institut Claudius Regaud | 2023-08-10 |
| A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC (NCT06328049) | Taixing People's Hospital | 2023-08-10 |
| A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals (NCT05997290) | BioNTech SE | 2023-08-10 |
| Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM (NCT05836259) | Tenaya Therapeutics | 2023-08-10 |
| A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours (NCT06237413) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2023-08-10 |
| Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases (NCT05746481) | Liza Villaruz, MD | 2023-08-10 |
| Reboxetine for Sleep Apnoea After ENT Surgery (NCT05978505) | Flinders University | 2023-08-10 |
| Maternal Probiotic Intervention to Improve Gut Health (NCT05922683) | Aga Khan University | 2023-08-09 |
| A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus (NCT06256549) | Gan and Lee Pharmaceuticals, USA | 2023-08-09 |
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors (NCT05958121) | Immatics Biotechnologies GmbH | 2023-08-09 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD) (NCT05984784) | Inmagene LLC | 2023-08-09 |
| The Primary Objective of This Study to Evaluate the Safety and Tolerability of IBI334 and Determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D)and Anti Tumor Activity of IBI334. (NCT05774873) | Innovent Biologics (Suzhou) Co. Ltd. | 2023-08-09 |
| 4D-150 in Patients With Diabetic Macular Edema (NCT05930561) | 4D Molecular Therapeutics | 2023-08-09 |
| Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer (NCT05843188) | University Health Network, Toronto | 2023-08-09 |